OSU RECEIVES $100 MILLION HRSA GRANT
On December 29, the Healh Resources and Services Administration (HRSA), and agency of the U.S. Department of Health & Human Services, announced The Ohio State University Wexner Medical Center as the sole recipient of a $100 million grant to help fund its expansion
efforts.US SENATOR BROWN RECEIVES 2010 JAMES HOPE AWARD US Senator Brown Honored at The Ohio State's James Cancer Hospital.
On June 24, we broke ground on ProjectONE. Dr. John Niederhuber, Director of the National Cancer Institute, gave the keynote address. ProjectONE is The Ohio State University Medical Center's $1 billion expansion and renovation plan. Building a new home for The Arthur G. James Cancer Hospital and Richard J. Solove Research Institution is a major component of ProjectONE. The new building will be completed in 2014 and will contain integrated spaces for research, education and patient care, allowing for the practice of more patient-centric and personalized care. Many thanks to our local, state and federal elected officials for coming to this historic occasion.
Nationwide, only 3 percent of cancer patients
enroll in clinical trials, which is slows our progress toward a
cancer-free world as clinical trials are how novel therapies become
standard treatments. When the Patient Protection and Affordable Care Act
was signed into law on March 23, 2010, it included a provision that
takes effect in 2014 that requires insurers cover routine care costs
when patients enroll on clinical trials. On the state level, the Ohio
General Assembly passed the Access to Cancer Clinical Trials Act in October 2008.
The components of the Patient Protection and Affordable Care Act are complex and inter-related. As federal agencies promulgate rules and regulations and the Ohio General Assembly enacts legislation to create a health care exchange, the Government Affairs team will remain engaged and maintain a dialogue with policymakers about what is important to Ohio State and the cancer care community. Several provisions of the reform measure will have a direct impact on cancer patients, most notably the requirement of coverage for standard of care coverage for patients enrolling in clinical trials.
CONGRESSWOMAN MARY JO KILROY VISITS OHIO STATE
Congresswoman Mary Jo Kilroy visited Ohio State's James Cancer Hospital.
CONGRESSMAN TIM RYAN VISITS OHIO STATE
Tim Ryan visited Ohio State's Biomedical Research Tower on Wednesday,
July 7. He toured the lab of Drs. Michael Ostrowski and Gustavo Leone,
who focus on cancer genetics. With Dr. Michael Grever, Congressman Ryan
was able to learn about Ohio State's plans to finish several floors of
the BRT, an action made possible through a grant Dr. Grever received as
part of the stimulus package. The Congressman finished his tour off with
a discussion about ProjectONE and a vision for Ohio State's future.
STATE ISSUE 1
On May 4th, the people of Ohio voted to continue the Third Frontier program. The program has resulted in more than 570 new companies, the expansion of existing companies and more than 48,000 new jobs for Ohioans. At Ohio State, Third Frontier Funds have boosted biomedical imaging.
CANCER PATIENT PROTECTION BILL
Cancer survivor Brandy Hickman testified on March 10, 2010 in support of HB 237, The Cancer Patient Protection Bill, sponsored by State Representative Deborah Newcomb, D-Conneaut. The companion to SB 133, sponsored by State Senator Karen Gillmor (R-Tiffin), the legislation would prohibit health plans from charging a higher co-payment, deductible or co-insurance amount for a prescribed, orally administered anticancer medication than what is required for an intravenously administered or injected cancer medication.
‘CONTINUITY OF CARE BILL’ EARNS SUPPORT TESTIMONY
Stacy Morton, a medication assistance program coordinator with the OSU Comprehensive Transplant Center, testitfied as a proponent of HB 453, a bill that would protect patients from the sudden and potentially dangerous substitution of medications due to insurance terms.